http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160088845-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a251ae79dd7a008d95010b238c6aa1f8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_566f661f7077c063795331740bb3180d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e630979b4deaf57e1f45c196fc55a73 |
| publicationDate | 2016-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20160088845-A |
| titleOfInvention | Composition for preventing or treating of inflammatory bowel disease |
| abstract | The present invention relates to a composition for preventing or treating an inflammatory bowel disease comprising any one selected from the group consisting of SMP30, an agonist thereof, and an agent for promoting the expression of SMP30, wherein the composition comprises a granulocyte colony stimulating factor and an inflammatory cytokine Expression can be suppressed, and intestinal inflammation can be suppressed. In addition, the present invention can be effectively used as a biomarker composition capable of diagnosing inflammatory bowel disease. In addition, the screening method for the therapeutic agent for inflammatory bowel disease comprising the step of promoting the expression of SMP30 according to the present invention or the step of selecting a candidate drug that activates SMP30 can be used to specifically select a drug that promotes or activates SMP30 expression, Can be effectively developed. |
| priorityDate | 2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.